Catherine Ramsey
Stock Analyst at Baird
(2.35)
# 1060
Out of 5,218 analysts
44
Total ratings
65.52%
Success rate
30.16%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Twist Bioscience | Maintains: Outperform | 46 48 | 47.54 | 0.97% | 5 | Nov 19, 2024 | |
Natera | Maintains: Outperform | 120 160 | 166.11 | -3.68% | 5 | Nov 13, 2024 | |
Illumina | Maintains: Neutral | 124 139 | 143.9 | -3.41% | 4 | Nov 6, 2024 | |
Revvity | Maintains: Outperform | 136 138 | 115.62 | 19.36% | 3 | Nov 5, 2024 | |
Castle Biosciences | Maintains: Outperform | 37 39 | 28.83 | 35.28% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 319 312 | 378.18 | -17.5% | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 3 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 695 665 | 527.13 | 26.15% | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 160 | 139.07 | 15.05% | 5 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 75 | 61.38 | 22.19% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 20 | n/a | n/a | 2 | Apr 24, 2020 |